This inventor holds 1 USPTO granted patent. Top assignee: Biogal Gyogyszergyar. Active years: 1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991
Title: Agnes Katona Nee Lendvay: Innovator in Pharmaceutical Compositions
Introduction
Agnes Katona Nee Lendvay is a notable inventor based in Debrecen, Hungary. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of ear infections. Her innovative work has led to the development of a unique pharmaceutical composition aimed at improving the health of patients suffering from external otitis and chronic otitis media.
Latest Patents
Agnes holds 1 patent for her invention titled "Pharmaceutical composition and process for preparing the same." This invention focuses on pharmaceutical compositions that are beneficial for patients with external otitis or otitis media. The composition includes a sulfhydryl-containing compound, an antibacterial chemotherapeutic agent, an aspecific anti-inflammatory agent, and optionally a keratolytic agent. Notably, N-acetyl-L-cysteine is used as the sulfhydryl-containing compound in her formulation.
Career Highlights
Agnes is associated with Biogal Gyogyszergyar, where she applies her expertise in pharmaceutical development. Her work has been instrumental in advancing treatments for ear-related ailments, showcasing her commitment to improving patient care through innovative solutions.
Collaborations
Agnes has collaborated with notable colleagues such as Gyula Kincses and Barna Kocsar. These partnerships have contributed to her research and development efforts, enhancing the impact of her inventions in the pharmaceutical industry.
Conclusion
Agnes Katona Nee Lendvay is a pioneering inventor whose work in pharmaceutical compositions has the potential to significantly improve the treatment of ear infections. Her dedication to innovation and collaboration continues to drive advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile